These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24849884)

  • 1. Bridging the financial gap through providing contract services: a model for publicly funded clinical biobanks.
    Kozlakidis Z; Mant C; Cason J
    Biopreserv Biobank; 2012 Aug; 10(4):357-60. PubMed ID: 24849884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Securing the sustainability of biobanks].
    Kirsten R; Hummel M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):390-5. PubMed ID: 26769112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
    Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
    Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustainability of Biobanks in the Future.
    De Souza YG
    Adv Exp Med Biol; 2015; 864():29-35. PubMed ID: 26420611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a business model to assure financial sustainability of biobanks.
    Warth R; Perren A
    Biopreserv Biobank; 2014 Dec; 12(6):389-94. PubMed ID: 25496150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output.
    Hofman V; Ilie M; Long E; Washetine K; Chabannon C; Figarella-Branger D; Clément B; Mabile L; Cambon-Thomsen A; Boucher P; Dagher G; Hewitt R; Parodi B; Hofman P
    Biopreserv Biobank; 2013 Aug; 11(4):235-44. PubMed ID: 24845591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.
    Parry-Jones A
    Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry involvement in publicly funded biobanks.
    Caulfield T; Borry P; Gottweis H
    Nat Rev Genet; 2014 Apr; 15(4):220. PubMed ID: 24772494
    [No Abstract]   [Full Text] [Related]  

  • 12. Financial stability in biobanking: unique challenges for disease-focused foundations and patient advocacy organizations.
    Bromley RL
    Biopreserv Biobank; 2014 Oct; 12(5):294-9. PubMed ID: 25313427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost model for biobanks.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; Morente MM; Fernández Lago O
    Biopreserv Biobank; 2013 Oct; 11(5):272-7. PubMed ID: 24835258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational research in pediatrics: tissue sampling and biobanking.
    Brisson AR; Matsui D; Rieder MJ; Fraser DD
    Pediatrics; 2012 Jan; 129(1):153-62. PubMed ID: 22144705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges for the Sustainability of University-Run Biobanks.
    Kongsholm NCH; Christensen ST; Hermann JR; Larsen LA; Minssen T; Pedersen LB; Rajam N; Tommerup N; Tupasela A; Schovsbo J
    Biopreserv Biobank; 2018 Aug; 16(4):312-321. PubMed ID: 30016130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proof-of-Concept Integration of Heterogeneous Biobank IT Infrastructures into a Hybrid Biobanking Network.
    Mate S; Kadioglu D; Majeed RW; Stöhr MR; Folz M; Vormstein P; Storf H; Brucker DP; Keune D; Zerbe N; Hummel M; Senghas K; Prokosch HU; Lablans M
    Stud Health Technol Inform; 2017; 243():100-104. PubMed ID: 28883179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience.
    Wilson GD; D'Angelo K; Pruetz BL; Geddes TJ; Larson DM; Akervall J
    Biopreserv Biobank; 2014 Oct; 12(5):306-11. PubMed ID: 25314610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to Make a Cost Model for the Birth Cohort Biobank in China.
    Wu M; Wu D; Hu C; Yan C
    Front Public Health; 2020; 8():24. PubMed ID: 32154203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Funding considerations for the disclosure of genetic incidental findings in biobank research.
    Black L; Avard D; Zawati MH; Knoppers BM; Hébert J; Sauvageau G;
    Clin Genet; 2013 Nov; 84(5):397-406. PubMed ID: 23662709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.